Pseudomonas infections in Tohid Burn Center, Iran
Burn injury is a major public health problem in many areas of the world. Pseudomonas aeruginosa is one of the most common causes of burn wound infection in burn patients. Septicemia due to this organism is a major cause of mortality among burn patients. This study analyzed P. aeruginosa infections i...
Gespeichert in:
| Veröffentlicht in: | Burns 1998-11, Vol.24 (7), p.637-641 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 641 |
|---|---|
| container_issue | 7 |
| container_start_page | 637 |
| container_title | Burns |
| container_volume | 24 |
| creator | Rastegar Lari, A Bahrami Honar, H Alaghehbandan, R |
| description | Burn injury is a major public health problem in many areas of the world.
Pseudomonas aeruginosa is one of the most common causes of burn wound infection in burn patients. Septicemia due to this organism is a major cause of mortality among burn patients. This study analyzed
P. aeruginosa infections in the Tohid Burn Center in Tehran during 1995–1997 in order to estimate their frequency, antibiotic susceptibility and their role in burn morbidity. Among 2122 patients who were admitted during this study period, 3365 bacterial strains were isolated and the frequency of
P. aeruginosa was 73.9%. This was followed by
Staphylococcus aureus (9.1%) and other organisms (17%) in frequency. The frequency of
P. aeruginosa resistant to gentamicin, carbenicillin, co-trimoxazole, ceftizoxime and tetracycline was over 95% and resistance to amikacin which was 49% in 1995, increased to 90% in 1997. With the introduction of ciprofloxacin at our burn center, the frequency of
P. aeruginosa resistance increased from 45% in 1995, to 82% in 1997.
P. aeruginosa was found more frequently in the ICU than in the wards. These findings show that
P. aeruginosa remains the leading cause of nosocomial infections in our burn center. It is necessary to introduce urgent measures for restriction of the spread of
P. aeruginosa infections in our burn center. |
| doi_str_mv | 10.1016/S0305-4179(98)00090-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69129966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0305417998000904</els_id><sourcerecordid>69129966</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-437c89a792bb9d1a1f5a6dd27f92f611767264f6f8d554045f4b6d95356c77963</originalsourceid><addsrcrecordid>eNqFkEtLAzEQgIMotVZ_QmEPIgquJrt5zUm0-CgUFKznkOaBkXZXk13Bf-9uW-rR0wzMN68PoTHBVwQTfv2KS8xySgScg7zAGAPO6R4aEikgJxTDPhrukEN0lNJHB2Em8QANQMoC82KIyEtyra1XdaVTFirvTBPqqk-zef0ebHbXxiqbuKpx8TKbRl0dowOvl8mdbOMIvT3czydP-ez5cTq5neWmlNDktBRGghZQLBZgiSaeaW5tITwUnhMiuCg49dxLyxjFlHm64BZYybgRAng5QmebuZ-x_mpdatQqJOOWS125uk2KAykAeA-yDWhinVJ0Xn3GsNLxRxGselVqrUr1HhRItValaNc33i5oFytnd11bN139dFvXyeil7343If0N7xAJPXazwVwn4zu4qJIJrjLOhtjZVLYO_xzyC4cNgr0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69129966</pqid></control><display><type>article</type><title>Pseudomonas infections in Tohid Burn Center, Iran</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rastegar Lari, A ; Bahrami Honar, H ; Alaghehbandan, R</creator><creatorcontrib>Rastegar Lari, A ; Bahrami Honar, H ; Alaghehbandan, R</creatorcontrib><description>Burn injury is a major public health problem in many areas of the world.
Pseudomonas aeruginosa is one of the most common causes of burn wound infection in burn patients. Septicemia due to this organism is a major cause of mortality among burn patients. This study analyzed
P. aeruginosa infections in the Tohid Burn Center in Tehran during 1995–1997 in order to estimate their frequency, antibiotic susceptibility and their role in burn morbidity. Among 2122 patients who were admitted during this study period, 3365 bacterial strains were isolated and the frequency of
P. aeruginosa was 73.9%. This was followed by
Staphylococcus aureus (9.1%) and other organisms (17%) in frequency. The frequency of
P. aeruginosa resistant to gentamicin, carbenicillin, co-trimoxazole, ceftizoxime and tetracycline was over 95% and resistance to amikacin which was 49% in 1995, increased to 90% in 1997. With the introduction of ciprofloxacin at our burn center, the frequency of
P. aeruginosa resistance increased from 45% in 1995, to 82% in 1997.
P. aeruginosa was found more frequently in the ICU than in the wards. These findings show that
P. aeruginosa remains the leading cause of nosocomial infections in our burn center. It is necessary to introduce urgent measures for restriction of the spread of
P. aeruginosa infections in our burn center.</description><identifier>ISSN: 0305-4179</identifier><identifier>EISSN: 1879-1409</identifier><identifier>DOI: 10.1016/S0305-4179(98)00090-4</identifier><identifier>PMID: 9882062</identifier><identifier>CODEN: BURND8</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - therapeutic use ; Bacterial diseases ; Bacterial diseases of the skin ; Biological and medical sciences ; Burn ; Burn Units - statistics & numerical data ; Burns - complications ; Burns - epidemiology ; Burns - microbiology ; Child ; Child, Preschool ; Drug Resistance, Microbial ; Drug Resistance, Multiple ; Human bacterial diseases ; Humans ; Incidence ; Infant ; Infectious diseases ; Iran - epidemiology ; Medical sciences ; Middle Aged ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - isolation & purification ; Pseudomonas aeruginosa - pathogenicity ; Pseudomonas infection ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - epidemiology ; Pseudomonas Infections - microbiology ; Retrospective Studies ; Skin - injuries ; Skin - microbiology ; Survival Rate ; Tropical medicine ; Wound Infection - drug therapy ; Wound Infection - epidemiology ; Wound Infection - microbiology</subject><ispartof>Burns, 1998-11, Vol.24 (7), p.637-641</ispartof><rights>1998 Elsevier Science Ltd</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-437c89a792bb9d1a1f5a6dd27f92f611767264f6f8d554045f4b6d95356c77963</citedby><cites>FETCH-LOGICAL-c389t-437c89a792bb9d1a1f5a6dd27f92f611767264f6f8d554045f4b6d95356c77963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0305417998000904$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1623892$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9882062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rastegar Lari, A</creatorcontrib><creatorcontrib>Bahrami Honar, H</creatorcontrib><creatorcontrib>Alaghehbandan, R</creatorcontrib><title>Pseudomonas infections in Tohid Burn Center, Iran</title><title>Burns</title><addtitle>Burns</addtitle><description>Burn injury is a major public health problem in many areas of the world.
Pseudomonas aeruginosa is one of the most common causes of burn wound infection in burn patients. Septicemia due to this organism is a major cause of mortality among burn patients. This study analyzed
P. aeruginosa infections in the Tohid Burn Center in Tehran during 1995–1997 in order to estimate their frequency, antibiotic susceptibility and their role in burn morbidity. Among 2122 patients who were admitted during this study period, 3365 bacterial strains were isolated and the frequency of
P. aeruginosa was 73.9%. This was followed by
Staphylococcus aureus (9.1%) and other organisms (17%) in frequency. The frequency of
P. aeruginosa resistant to gentamicin, carbenicillin, co-trimoxazole, ceftizoxime and tetracycline was over 95% and resistance to amikacin which was 49% in 1995, increased to 90% in 1997. With the introduction of ciprofloxacin at our burn center, the frequency of
P. aeruginosa resistance increased from 45% in 1995, to 82% in 1997.
P. aeruginosa was found more frequently in the ICU than in the wards. These findings show that
P. aeruginosa remains the leading cause of nosocomial infections in our burn center. It is necessary to introduce urgent measures for restriction of the spread of
P. aeruginosa infections in our burn center.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the skin</subject><subject>Biological and medical sciences</subject><subject>Burn</subject><subject>Burn Units - statistics & numerical data</subject><subject>Burns - complications</subject><subject>Burns - epidemiology</subject><subject>Burns - microbiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Resistance, Multiple</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Iran - epidemiology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - isolation & purification</subject><subject>Pseudomonas aeruginosa - pathogenicity</subject><subject>Pseudomonas infection</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - epidemiology</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Retrospective Studies</subject><subject>Skin - injuries</subject><subject>Skin - microbiology</subject><subject>Survival Rate</subject><subject>Tropical medicine</subject><subject>Wound Infection - drug therapy</subject><subject>Wound Infection - epidemiology</subject><subject>Wound Infection - microbiology</subject><issn>0305-4179</issn><issn>1879-1409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLAzEQgIMotVZ_QmEPIgquJrt5zUm0-CgUFKznkOaBkXZXk13Bf-9uW-rR0wzMN68PoTHBVwQTfv2KS8xySgScg7zAGAPO6R4aEikgJxTDPhrukEN0lNJHB2Em8QANQMoC82KIyEtyra1XdaVTFirvTBPqqk-zef0ebHbXxiqbuKpx8TKbRl0dowOvl8mdbOMIvT3czydP-ez5cTq5neWmlNDktBRGghZQLBZgiSaeaW5tITwUnhMiuCg49dxLyxjFlHm64BZYybgRAng5QmebuZ-x_mpdatQqJOOWS125uk2KAykAeA-yDWhinVJ0Xn3GsNLxRxGselVqrUr1HhRItValaNc33i5oFytnd11bN139dFvXyeil7343If0N7xAJPXazwVwn4zu4qJIJrjLOhtjZVLYO_xzyC4cNgr0</recordid><startdate>19981101</startdate><enddate>19981101</enddate><creator>Rastegar Lari, A</creator><creator>Bahrami Honar, H</creator><creator>Alaghehbandan, R</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981101</creationdate><title>Pseudomonas infections in Tohid Burn Center, Iran</title><author>Rastegar Lari, A ; Bahrami Honar, H ; Alaghehbandan, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-437c89a792bb9d1a1f5a6dd27f92f611767264f6f8d554045f4b6d95356c77963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the skin</topic><topic>Biological and medical sciences</topic><topic>Burn</topic><topic>Burn Units - statistics & numerical data</topic><topic>Burns - complications</topic><topic>Burns - epidemiology</topic><topic>Burns - microbiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Resistance, Multiple</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Iran - epidemiology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - isolation & purification</topic><topic>Pseudomonas aeruginosa - pathogenicity</topic><topic>Pseudomonas infection</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - epidemiology</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Retrospective Studies</topic><topic>Skin - injuries</topic><topic>Skin - microbiology</topic><topic>Survival Rate</topic><topic>Tropical medicine</topic><topic>Wound Infection - drug therapy</topic><topic>Wound Infection - epidemiology</topic><topic>Wound Infection - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rastegar Lari, A</creatorcontrib><creatorcontrib>Bahrami Honar, H</creatorcontrib><creatorcontrib>Alaghehbandan, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Burns</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rastegar Lari, A</au><au>Bahrami Honar, H</au><au>Alaghehbandan, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pseudomonas infections in Tohid Burn Center, Iran</atitle><jtitle>Burns</jtitle><addtitle>Burns</addtitle><date>1998-11-01</date><risdate>1998</risdate><volume>24</volume><issue>7</issue><spage>637</spage><epage>641</epage><pages>637-641</pages><issn>0305-4179</issn><eissn>1879-1409</eissn><coden>BURND8</coden><abstract>Burn injury is a major public health problem in many areas of the world.
Pseudomonas aeruginosa is one of the most common causes of burn wound infection in burn patients. Septicemia due to this organism is a major cause of mortality among burn patients. This study analyzed
P. aeruginosa infections in the Tohid Burn Center in Tehran during 1995–1997 in order to estimate their frequency, antibiotic susceptibility and their role in burn morbidity. Among 2122 patients who were admitted during this study period, 3365 bacterial strains were isolated and the frequency of
P. aeruginosa was 73.9%. This was followed by
Staphylococcus aureus (9.1%) and other organisms (17%) in frequency. The frequency of
P. aeruginosa resistant to gentamicin, carbenicillin, co-trimoxazole, ceftizoxime and tetracycline was over 95% and resistance to amikacin which was 49% in 1995, increased to 90% in 1997. With the introduction of ciprofloxacin at our burn center, the frequency of
P. aeruginosa resistance increased from 45% in 1995, to 82% in 1997.
P. aeruginosa was found more frequently in the ICU than in the wards. These findings show that
P. aeruginosa remains the leading cause of nosocomial infections in our burn center. It is necessary to introduce urgent measures for restriction of the spread of
P. aeruginosa infections in our burn center.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>9882062</pmid><doi>10.1016/S0305-4179(98)00090-4</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-4179 |
| ispartof | Burns, 1998-11, Vol.24 (7), p.637-641 |
| issn | 0305-4179 1879-1409 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69129966 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Bacterial diseases Bacterial diseases of the skin Biological and medical sciences Burn Burn Units - statistics & numerical data Burns - complications Burns - epidemiology Burns - microbiology Child Child, Preschool Drug Resistance, Microbial Drug Resistance, Multiple Human bacterial diseases Humans Incidence Infant Infectious diseases Iran - epidemiology Medical sciences Middle Aged Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - isolation & purification Pseudomonas aeruginosa - pathogenicity Pseudomonas infection Pseudomonas Infections - drug therapy Pseudomonas Infections - epidemiology Pseudomonas Infections - microbiology Retrospective Studies Skin - injuries Skin - microbiology Survival Rate Tropical medicine Wound Infection - drug therapy Wound Infection - epidemiology Wound Infection - microbiology |
| title | Pseudomonas infections in Tohid Burn Center, Iran |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pseudomonas%20infections%20in%20Tohid%20Burn%20Center,%20Iran&rft.jtitle=Burns&rft.au=Rastegar%20Lari,%20A&rft.date=1998-11-01&rft.volume=24&rft.issue=7&rft.spage=637&rft.epage=641&rft.pages=637-641&rft.issn=0305-4179&rft.eissn=1879-1409&rft.coden=BURND8&rft_id=info:doi/10.1016/S0305-4179(98)00090-4&rft_dat=%3Cproquest_cross%3E69129966%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69129966&rft_id=info:pmid/9882062&rft_els_id=S0305417998000904&rfr_iscdi=true |